Visual Versus semi-quantitative analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) project

Journal of Alzheimer's Disease

Volumn 44, Issue 3, 2015, Pages 815-826

  Morbelli, Silvia ^a   Brugnolo, Andrea ^a   Bossert, Irene ^a   Buschiazzo, Ambra ^a   Frisoni, Giovanni B ^b,c   Galluzzi, Samantha ^b   Van Berckel, Bart N M ^d   Ossenkoppele, Rik ^d   Perneczky, Robert ^e,f,g   Drzezga, Alexander ^g,m   Didic, Mira ^h   Guedj, Eric ⁱ   Sambuceti, Gianmario ^a   Bottoni, Gianluca ^a   Arnaldi, Dario ^a   Picco, Agnese ^a   De Carli, Fabrizio ^j   Pagani, Marco ^k,l   Nobili, Flavio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f West London Cognitive Disorders Treatment and Research Unit   (United Kingdom)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h AIX MARSEILLE UNIVERSITY   (France)

ⁱ TIMONE HOSPITAL   (France)

^j CNR   (Italy)

^k INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Alzheimer's disease; amnestic mild cognitive impairment; FDG PET; PALZ score; visual read

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BRAIN LEVEL; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; COMPLICATION; DIAGNOSTIC USE; EUROPE; FOLLOW UP; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGICAL RATING SCALE; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; EUROPE; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY;

EID: 84922617690     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142229     Document Type: Article

References (49)

1. Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD (2011) Review and meta-analysis of biomarkers and diag nostic imaging in Alzheimer's disease. J Alzheimers Dis 26, 627-645.
2. Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S (2012) Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature. J Nucl Med 53, 59-71.
3. Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR Jr, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C; ISTAART's NeuroImaging Professional Interest Area (2013) Imaging markers for Alzheimer disease: Which vs how. Neurology 81, 487-500.
4. Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative (2011) Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage 56, 52-60.
5. Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, Pastor P, Riverol M, Gómez-Isla MT, Peñuelas I, Richter JA, Weiner MW; Alzheimer's Disease Neuroimaging Initiative (2010) Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia. Eur J Nucl Med Mol Imaging 40, 1394-405.
6. Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative (2012) Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: Head-to-head comparison. J Nucl Med 53, 592-600.
7. Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative (2013) Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266, 583-591.
8. Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A; Alzheimer's Disease Neuroimaging Initiative (2014) Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Neurobiol Aging 35, 143-151.
9. Young J, Modat M, Cardoso MJ, Mendelson A, Cash D, Ourselin S; Alzheimer's Disease Neuroimaging Initiative (2013) Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clin 2, 735-745.
10. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J (2002) Natural history of mild cognitive impairment in older persons. Neurology 59, 198-205.
11. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S,Marcone A, Miele R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D (2005) Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 62, 1728-1733.
12. Morbelli S, Piccardo A,Villavecchia G, Dessi B, Brugnolo A, Piccini A, Caroli A, Frisoni G, Rodriguez G, Nobili F (2010) Mapping brain morphological and functional conversion patterns in amnestic MCI: A voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging 37, 36-45.
13. Nobili F, Salmaso D, Morbelli S, Girtler N, Piccardo A, Brugnolo A, Dessi B, Larsson SA, Rodriguez G, Pagani M (2008) Principal component analysis of FDG PET in amnestic MCI. Eur J Nucl Med Mol Imaging 35, 2191-2202.
14. Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A, Mazzei D, Villavecchia G, Larsson SA, Rodriguez G, Nobili F (2010) MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Curr Alzheimer Res 7, 287-294.
15. Lehman VT, Carter RE, Claassen DO, Murphy RC, Lowe V, Petersen RC, Peller PJ (2012) Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med 37, 721-726.
16. Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Nagren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K; European Association of Nuclear Medicine Neuroimaging Committee (2009) EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging 36, 2103-2110.
17. Herholz K, Salmon E, Perani D, Baron JC, HolthoffV, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schröder J, Kato T, Arahata Y, Henze M, Heiss WD (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17, 302-316.
18. Herholz K, Westwood S, Haense C, Dunn G (2011) Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment. J Nucl Med 52, 1218-1226.
19. Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Sambuceti G, Pagani M, Salmon E, Nobili F (2012) Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging 33, 2533-2550.
20. Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Naseri M, Sambuceti G, Pagani M, Nobili F (2013) Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease:AEuropean Alzheimer disease consortium project. J Nucl Med 54, 894-902.
21. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report ofthe NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
23. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
24. McKeith IG, DicksonDW,Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863-1872.
25. Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, Tatsch K; European Association of Nuclear Medicine (2002) European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. Eur J Nucl Med Mol Imaging 29, BP43-48.
26. Brown LD, Cai TT, Das Gupta A (2001) Interval estimation for a binomial proportion. Statist Sci 16, 101-133.
27. Simel DL, Samsa GP, Matchar DB (1991) Likelihood ratios with confidence: Sample size estimation for diagnostic test studies. J Clin Epidemiol 44, 763-70.
28. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiol 56, 1129-1135.
29. Leisenring WJ, Alonzo T, Pepe MS (2000) Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 56, 345-351.
30. Nofuentes JA, Del Castillo JD (2007) Comparison of the likelihood ratios of two binary diagnostic tests in paired designs. Statist Med 26, 4179-4201.
31. Suzuki SJ (2006) Conditional relative odds ratio and comparison of accuracy of diagnostic tests based on 2?2 tables. Epidemiology 16, 145-153.
32. Xia Y, Lu S, Wen L, Eberl S, Fulham M, Feng DD (2014) Automated identification of dementia using FDG-PET imaging. Biomed Res Int 2014, 421743.
33. Zahn R, Juengling F, Bubrowski P, Jost E, Dykierek P, Talazko J, Huell M (2004) Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: A study using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 132, 159-172.
34. Rodriguez G, Nobili F, De Carli F, Francione S, Marenco S, Celestino MA, Hassan K, Rosadini G (1993) Regional cerebral blood flow in chronic stroke patients. Stroke 24, 94-99.
35. Galluzzi S, Geroldi C, Ghidoni R, Paghera B, Amicucci G, Bonetti M, Zanetti O, Cotelli M, Gennarelli M, Frisoni GB; Translational Outpatient Memory ClinicWorking Group (2010) The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment. J Neurol 257, 2004-2014.
36. Chincarini A, Bosco P, Gemme G, Esposito M, Rei L, Squarcia S, Bellotti R, Minthon L, Frisoni G, Scheltens P, Frölich L, Soininen H, Visser PJ, Nobili F; Alzheimer's Disease Neuroimaging Initiative (2014) Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study. Alzheimers Dement 10, 456-467.
37. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr,WeinerMW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative (2010) Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230-238.
38. Haense C, Herholz K, Jagust WJ, Heiss WD (2009) Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord 28, 259-266.
39. Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE (1996) Alzheimer disease: Improved visual interpretation of PET images by using three-dimensional stereotactic surface projections. Radiology 198, 837-843.
40. Ishii K, Kono AK, Sasaki H, Miyamoto N, Fukuda T, Sakamoto S, Mori E (2006) Fully automatic diagnostic system forearly-and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP. Eur J Nucl Med Mol Imaging 33, 575-583.
41. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804.
42. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
43. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P,Wiste HJ,Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
44. Elias A,Woodward M, Rowe CC (2014) Management impact of FDG-PET in dementia: Results from a tertiary center memory clinic. J Alzheimers Dis 42, 885-892.
45. Wee LE, YeoWX, Yang GR, Hannan N, Lim K, Chua C, Tan MY, Fong N, Yeap A, Chen L, Koh GC, Shen HM (2012) Individual and area level socioeconomic status and its association with cognitive function and cognitive impairment (low MMSE) among community-dwelling elderly in Singapore. Dement Geriatr Cogn Dis Extra 2, 529-542.
46. Makin SD, Turpin S, Dennis MS, Wardlaw JM (2013) Cognitive impairment after lacunar stroke: Systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 84, 893-900.
47. Christa Maree SB, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG (2013) Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: A systematic review. BMJ Open 3, pii: e001909.
48. Bohnen NI, Minoshima S (2012) FDG-PET and molecular brain imaging in the movement disorders clinic. Neurology 79, 1306-1307.
49. Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, OldeRikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR,Winblad B,Wahlund LO,Wilcock G, Visser PJ (2013) Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study. Dement Geriatr Cogn Disord 36, 1-19.